deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT04530708

Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC (MARS)

Multicentre Phase III Study: Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC

Sponsor: Swedish Lung Cancer Study Group

Conditions Non Small Cell Lung Cancer Quality of Life Radiotherapy Stage IV Non-small Cell Lung Cancer
Interventions Thoracic radiotherapy
Updated 5 times since 2020 Last updated: Aug 25, 2020 Started: Feb 1, 2017 Primary completion: Feb 1, 2024 Completion: Feb 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Non Small Cell Lung Cancer and Quality of Life and is currently ongoing. Swedish Lung Cancer Study Group leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotRecruiting~Feb 2026 – present · 5 months · monthly snapshot

Change History

5 versions recorded

  1. Feb 2026 — Present [monthly]

    Unknown NA

    Status: Recruiting → Unknown

  2. Sep 2024 — Feb 2026 [monthly]

    Recruiting NA

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Jan 2021 — Jul 2024 [monthly]

    Recruiting NA

  5. Sep 2020 — Jan 2021 [monthly]

    Recruiting NA

    First recorded

Feb 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Swedish Lung Cancer Study Group
Data source: Swedish Lung Cancer Study Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations